These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation. Clin Allergy; 1974 Mar; 4(1):1-12. PubMed ID: 4824569 [No Abstract] [Full Text] [Related]
16. The influence of age and sex on the incidence of the 'flu' syndrome and rifampicin-dependent antibodies in patients on intermittent rifampicin for tuberculosis. Tubercle; 1975 Sep; 56(3):173-8. PubMed ID: 766339 [No Abstract] [Full Text] [Related]
17. [Presence of antibodies against rifampicin in patients under tuberculostatic treatment]. Ion N; Jemma I; Sfetcu V Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(1):39-42. PubMed ID: 6264569 [TBL] [Abstract][Full Text] [Related]
18. [Severe immunoallergic reaction in a patient treated for two months continuously with rifampicin]. Fardet L; Lalande V; Meyohas MC; Frottier J; Meynard JL Presse Med; 1999 Nov; 28(37):2037-8. PubMed ID: 10605471 [TBL] [Abstract][Full Text] [Related]
19. Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong. Clin Allergy; 1975 Jun; 5(2):189-99. PubMed ID: 1095248 [TBL] [Abstract][Full Text] [Related]
20. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects. Eule H; Werner E; Winsel K; Iwainsky H Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295 [No Abstract] [Full Text] [Related] [Next] [New Search]